

Aggreko: Morgan Stanley ups target price from 1350p to 1375p, while leaving its underweight rating unaltered. Alliance Pharma: Canaccord Genuity lower...


- HSBC China services PMI jumps to 17-month high - Investors digest weak Eurozone services data, await UK figures - Ashtead ups full-year view after s...